undamentalytics Newsletter
Sign in

Datameds AI, Inc. key statistics and ratios

In fiscal 2025, Datameds AI, Inc. had an operating margin of -401.7% and a current ratio of 0.09. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Gross margin9.7%−27.5%−90.6%
Operating margin−33.9%−401.7%−875.7%
Net margin−37.8%−433.9%<−999%
Return on equity−101.8%——
Return on assets−12.0%−230.7%−279.3%
Asset turnover0.320.530.25
Current ratio0.400.090.14
Debt to equity347.2%——
Interest cover (operating income ÷ interest)n/mn/mn/m

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

0 of 5 checks passed · June 30, 2026
What it owns · $33m
Short-term assets $6mLonger-term assets $27m
What it owes, and who funded it · $52m
Short-term liabilities $39mLonger-term liabilities $13mShareholders' equity $-20m
  • Short-term assets cover short-term liabilities $6m of assets due within a year against $39m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $6m short-term assets against $13m of longer-dated liabilities.
  • More cash than debt $2m of cash against $32m of debt.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt −$14m of operating cash flow against $32m of debt.
  • Operating profit covers interest at least five times over Operating income of −$70m against $6m of interest.

From Datameds AI, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: MEDS vs MNDRDRIO vs MEDSMEDS vs WORX

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Datameds AI, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Datameds AI, Inc.